Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Hiroaki Ogata, Akiko Takeshima & Hidetoshi Ito. (2022) An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles. Expert Opinion on Drug Safety 21:7, pages 947-955.
Read now
Read now
Michel Vallée, Jordan Weinstein, Marisa Battistella, Roxanne Papineau, Dianne Moseley & Gordon Wong. (2021) Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. International Journal of Nephrology and Renovascular Disease 14, pages 301-311.
Read now
Read now
Jose Antonio Herrero, Mario Salomone, Antonio Ramirez de Arellano, Thilo Schaufler & Sebastian Walpen. (2021) Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis. Journal of Medical Economics 24:1, pages 1240-1247.
Read now
Read now
Lijuan Zhao, An Liu & Guoshuang Xu. (2021) Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis. Renal Failure 43:1, pages 1378-1393.
Read now
Read now
Ebele M Umeukeje, Amanda S Mixon & Kerri L Cavanaugh. (2018) Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Preference and Adherence 12, pages 1175-1191.
Read now
Read now
Stuart M. Sprague & Jürgen Floege. (2018) Sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Expert Opinion on Pharmacotherapy 19:10, pages 1137-1148.
Read now
Read now
Fabio Carfagna, Lucia Del Vecchio, Giuseppe Pontoriero & Francesco Locatelli. (2018) Current and potential treatment options for hyperphosphatemia. Expert Opinion on Drug Safety 17:6, pages 597-607.
Read now
Read now
Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine Buemi & Michele Buemi. (2016) Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. International Journal of Nephrology and Renovascular Disease 9, pages 11-19.
Read now
Read now
J. Bover, P. Ureña-Torres, M. J. Lloret, C. Ruiz-García, I. DaSilva, M. M. Diaz-Encarnacion, C. Mercado, S. Mateu, E. Fernández & J. Ballarin. (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy 17:9, pages 1247-1258.
Read now
Read now
Valeria Cernaro, Domenico Santoro, Silvia Lucisano, Giacomo Nicocia, Antonio Lacquaniti & Michele Buemi. (2014) The future of phosphate binders: a perspective on novel therapeutics. Expert Opinion on Investigational Drugs 23:11, pages 1459-1463.
Read now
Read now
Articles from other publishers (36)
Valeria Cernaro, Michela Calderone, Guido Gembillo, Vincenzo Calabrese, Chiara Casuscelli, Claudia Lo Re, Elisa Longhitano & Domenico Santoro. (2023) Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions. Nutrients 15:14, pages 3161.
Crossref
Crossref
Parminder Nain, Narendra Nayak, Mary C. Maj, Rohit Kumar Singh, Jaspreet Kaur, Yujin Jeong, Sabyasachi Maity, Reetuparna Nath, Robert H. Hilgers, Shreya Nauhria & Samal Nauhria. (2023) Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study. Pharmacy 11:1, pages 27.
Crossref
Crossref
Sawsan M Al Blewi, Aeshah A AlAzmi, Nagla Elimam, Wasil Jastaniah, Abdullah Mohammedkhalil & Shaker Abdullah. (2023) A Retrospective Single-Center Study of Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Children With Tumor Lysis Syndrome. Cureus.
Crossref
Crossref
Han Jiang, Lihua Li, Lili Zhang, Guangyao Zang, Zhen Sun & Zhongqun Wang. (2022) Role of endothelial cells in vascular calcification. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Darius L. Mason, Kavitha Godugu, Daryl Nnani & Shaker A. Mousa. (2021) Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease. Clinical and Translational Science 15:2, pages 353-360.
Crossref
Crossref
Mark Sampson, Nuno Faria & Jonathan J Powell. (2021) Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease. Nephrology Dialysis Transplantation 36:8, pages 1399-1407.
Crossref
Crossref
Yan Gao, Haisong Zhang, Yanbo Zuo, Weihua Song, Libin Bai, Hailei Zhang, Hongjie Wang, Yonggang Wu & Xinwu Ba. (2020) Preparation of allylamine-grafted cellulose by Ce(IV): a desirable candidate of oral phosphate binders. Polymer Bulletin 78:5, pages 2537-2552.
Crossref
Crossref
Anjay Rastogi, Nisha Bhatt, Sandro Rossetti & Judith Beto. (2021) Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm. Journal of Renal Nutrition 31:1, pages 21-34.
Crossref
Crossref
Chia-Ter Chao & Shih-Hua Lin. (2020) Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins. Toxins 12:12, pages 812.
Crossref
Crossref
Annabel Biruete, Kathleen M. Hill Gallant, Stephen R. Lindemann, Gretchen N. Wiese, Neal X. Chen & Sharon M. Moe. (2020) Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract. Journal of Renal Nutrition 30:1, pages 4-10.
Crossref
Crossref
Joanne Laycock, Malgorzata Furmanik, Mengxi Sun, Leon J. Schurgers, Rukshana Shroff & Catherine M. Shanahan. 2020. Cardiovascular Calcification and Bone Mineralization. Cardiovascular Calcification and Bone Mineralization
137
166
.
Dan Martinusen, Judith G. Marin, Elaine Cheng & Wynnie Lau. 2020. Renal Medicine and Clinical Pharmacy. Renal Medicine and Clinical Pharmacy
45
115
.
Atsushi Yaguchi, Kenji Akahane, Kumi Tsuchioka, Saori Yonekubo, Shota Yamamoto, Yasuaki Tamai, Satoshi Tatemichi & Hiroo Takeda. (2019) A comparison between the combined effect of calcium carbonate with sucroferric oxyhydroxide and other phosphate binders: an in vitro and in vivo experimental study. BMC Nephrology 20:1.
Crossref
Crossref
Jessica Kendrick, Vidhya Parameswaran, Linda H. Ficociello, Norma J. Ofsthun, Shannon Davis, Claudy Mullon, Robert J. Kossmann & Kamyar Kalantar-Zadeh. (2019) One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis. Journal of Renal Nutrition 29:5, pages 428-437.
Crossref
Crossref
Karolina Wieszczycka, Katarzyna Staszak, Marta J. Woźniak-Budych & Stefan Jurga. (2019) Lanthanides and tissue engineering strategies for bone regeneration. Coordination Chemistry Reviews 388, pages 248-267.
Crossref
Crossref
Grzegorz B. Wasilewski, Marc G. Vervloet & Leon J. Schurgers. (2019) The Bone—Vasculature Axis: Calcium Supplementation and the Role of Vitamin K. Frontiers in Cardiovascular Medicine 6.
Crossref
Crossref
Francesco Locatelli, Fabio Carfagna, Lucia Del Vecchio & Vincenzo La Milia. (2018) Haemodialysis or haemodiafiltration: that is the question. Nephrology Dialysis Transplantation 33:11, pages 1896-1904.
Crossref
Crossref
Allison B. Reiss, Nobuyuki Miyawaki, Jane Moon, Lora J. Kasselman, Iryna Voloshyna, Robert D'AvinoJr.Jr. & Joshua De Leon. (2018) CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis 278, pages 49-59.
Crossref
Crossref
Xiuqin Yang, Qingning Bai, Yanguo Li, Haijun Liu, Haiying Guo & Xiaolei Zhang. (2017) Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease. Journal of Parenteral and Enteral Nutrition 42:4, pages 766-777.
Crossref
Crossref
Lucie Hénaut, Jean-Marc Chillon, Saïd Kamel & Ziad A. Massy. (2018) Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease. Seminars in Nephrology 38:3, pages 233-250.
Crossref
Crossref
Fang Wang, Xiangxue Lu, Jingli Zhang, Ruifang Xiong, Han Li & Shixiang Wang. (2018) Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials. Kidney and Blood Pressure Research 43:2, pages 536-544.
Crossref
Crossref
Fohona S. Coulibaly, Miezan J. M. Ezoulin, Sudhaunshu S. Purohit, Navid J. Ayon, Nathan A. Oyler & Bi-Botti C. Youan. (2017) Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physicochemical and Biological Properties. Molecular Pharmaceutics 14:10, pages 3512-3527.
Crossref
Crossref
Diana Jalal, Molly McFadden, Jamie P. Dwyer, Kausik Umanath, Erwin Aguilar, Yoram Yagil, Barbara Greco, Mohammed Sika, Julia B. Lewis, Tom Greene & Simin Goral. (2017) Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis. Hemodialysis International 21:2, pages 243-249.
Crossref
Crossref
Nigar Sekercioglu, Argie Angeliki Veroniki, Lehana Thabane, Jason W. Busse, Noori Akhtar-Danesh, Alfonso Iorio, Luciane Cruz Lopes & Gordon H. Guyatt. (2017) Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA. PLOS ONE 12:3, pages e0171028.
Crossref
Crossref
Annabel Biruete, Jin Hee Jeong, Jennifer L. Barnes & Kenneth R. Wilund. (2017) Modified Nutritional Recommendations to Improve Dietary Patterns and Outcomes in Hemodialysis Patients. Journal of Renal Nutrition 27:1, pages 62-70.
Crossref
Crossref
Haisong Zhang, Meng Yu, Hailei Zhang & Libin Bai. (2016) Facile preparation and evaluation of allylamine hydrochloride-based porous hydrogel without calcium and aluminum: an alternative candidate of phosphate binder. Polymer Bulletin 73:12, pages 3371-3384.
Crossref
Crossref
Steven Habbous, Sebastian Przech, Rey Acedillo, Sisira Sarma, Amit X. Garg & Janet Martin. (2016) The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrology Dialysis Transplantation, pages gfw312.
Crossref
Crossref
Nigar Sekercioglu, Lehana Thabane, Juan Pablo Díaz Martínez, Gihad Nesrallah, Christopher J. Longo, Jason W. Busse, Noori Akhtar-Danesh, Arnav Agarwal, Reem Al-Khalifah, Alfonso Iorio & Gordon H. Guyatt. (2016) Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. PLOS ONE 11:6, pages e0156891.
Crossref
Crossref
Rana Rizk, Mickaël Hiligsmann, Mirey Karavetian & Silvia MAA Evers. (2016) Economic evaluations of interventions to manage hyperphosphataemia in adult haemodialysis patients: A systematic review. Nephrology 21:3, pages 178-187.
Crossref
Crossref
Usama Abdel Azim Sharaf El Din, Mona Mansour Salem & Dina Ossama Abdulazim. (2016) Vascular calcification: When should we interfere in chronic kidney disease patients and how?. World Journal of Nephrology 5:5, pages 398.
Crossref
Crossref
Usama Abdel Azim Sharaf El Din, Mona Mansour Salem & Dina Ossama Abdulazim. (2016) Stop chronic kidney disease progression: Time is approaching. World Journal of Nephrology 5:3, pages 258.
Crossref
Crossref
Stuart M. Sprague, Adrian C. Covic, Jürgen Floege, Markus Ketteler, Jaco Botha, Edward M. Chong & Anjay Rastogi. (2016) Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients. American Journal of Nephrology 44:2, pages 104-112.
Crossref
Crossref
Da Shang, Qionghong Xie, Xiaolin Ge, Huanqing Yan, Jing Tian, Dingwei Kuang, Chuan-Ming Hao & Tongying Zhu. (2015) Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients. BMC Nephrology 16:1.
Crossref
Crossref
Wajeh Y. Qunibi. (2015) Is It Too Much of a Good Thing? A New Era in Phosphate Binder Therapy in ESRD. Journal of the American Society of Nephrology 26:10, pages 2311-2313.
Crossref
Crossref
N. Jiang, W. Fang, A.P. Gu, J.Z. Yuan, X.X. Yang, A.W. Lin, Z.H. Ni & J.Q. Qian. (2015) Improving diet recipe and cooking methods attenuates hyperphosphatemia in patients undergoing peritoneal dialysis. Nutrition, Metabolism and Cardiovascular Diseases 25:9, pages 846-852.
Crossref
Crossref
Viatcheslav Rakov, Edward Chong & Jennifer Parker. (2014) Tackling non-adherence in dialysis patients with hyperphosphataemia. Journal of Renal Nursing 6:6, pages 273-279.
Crossref
Crossref